(Total Views: 938)
Posted On: 11/20/2020 1:30:25 AM
Post# of 154098
Quote:
The data supporting this EUA for baricitinib combined with remdesivir are based on a randomized, double-blind, placebo-controlled clinical trial (ACTT-2), which was conducted by the National Institute of Allergy and Infectious Diseases (NIAID).
Another Fauci special
(3)
(0)
